Abstract
The complex signaling pathways and interactions inside and among cells which are responsible for the appearance and evolving of malignancy have a distinct and well separated border, the translation process, where the signals of a mutant and dysregulating genome are becoming specific proteins evolving to the malignant phenotype. We selected as translation target the Fragile X–Mental Retardation Protein (FMRP) of the breast cancer cell, a protein of whose role in translation has not clearly elucidated yet. Triple negative breast cancer cell lines (BCCL)-(BT20, MDA-MB-231, Hs578 T) were transfected by plasmid with mutant FMRP at progressively increased CGG triplets (from 45 to 200 repeats at a one by one CGG repeat step up process) and the production of the mutant protein was verified with the SUNSET method and Western blot analysis. Afterwards, the impact in proteinosynthesis inhibition and apoptosis induction of the transfected BCCL in relation to normal epithelial breast cell lines (NEBCL) was evaluated. Preliminary in vitro results showed slower rates of proteinosynthesis and higher apoptotic rate of the 78 CGG & 84 CGG repeat mutant FMRP transfected BCCL in compared to NEBCL, while for all other transfected BCCL no statistically significant differentiation was found.
Article PDF
Avoid common mistakes on your manuscript.
References
Laetitia Michelle. Thèse présentée à la Faculté de Médecine et des Sciences de la Santé en vue d’obtention du titre de PhD. Les protéines du complexe exon-jonction (EJC) régulent l’épissage alternatif du transcript Bcl-x, ainsi que d’autres transcrits reliés au contrôle de l’apoptose et du cycle cellulaire. Library and Archives Canada–ISBN 9780-0-494-89960-0
Matsuo H, Li H, McGuire AM, et al. Structure of translation factor eIF4E bound to m7GDP and interaction with 4E-binding protein. Nat Struct Biol 1997; 4:717–24
Lucá R, Averna M, Zalfa F, et al. The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation. EMBO Mol Med 2013; 5:1523–36
Blice-Baum AC, Mihailescu M-R. Biophysical characterization of G-quadruplex forming FMR1 mRNA and of its interactions with different fragile X mental retardation protein isofoforms. RNA 2014; 20:103–14
Fantozzi A, Christofori G. Mouse model of breast cancer metastasis. Breast Cancer Res. 2006; 8:212
Takahashi S, Ito Y, Hatake K, et al. Gene therapy for breast cancer. Reiew of clinical gene therapy trials for breast cancer and MDR1 gene therapy trial in Cancer Institute Hospital. Breast Cancer 2006; 13:8–15
Nishikata T, Ishikawa M, Matsuyama T, et al. Primary culture of breast cancer: a model system for epithelial-mesenchymal transition and cancer stem cells. Anticancer Res 2013; 33: 2867–3
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bouras, P. Novel therapeutic protocol in the research of breast cancer treatment - Targeting the border. Hellenic J Surg 88, 295–296 (2016). https://doi.org/10.1007/s13126-016-0336-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13126-016-0336-4